Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 Fonds
26,84
EUR
-1,14
EUR
-4,07
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 9,76% |
| UnitedHealth Group Inc | US91324P1021 | 5,36% |
| AstraZeneca PLC | GB0009895292 | 4,06% |
| Boston Scientific Corp | US1011371077 | 3,19% |
| Sanofi SA | FR0000120578 | 3,14% |
| Abbott Laboratories | US0028241000 | 3,02% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 2,93% |
| AbbVie Inc | US00287Y1091 | 2,57% |
| Amgen Inc | US0311621009 | 2,52% |
| Novartis AG ADR | US66987V1098 | 2,43% |
| Sonstige | 61,01% |